Physician profile
Michael E Albo
NPI 1912938499
$5,502.44
in general payments reported to CMS, 2019-2025
24 companies · $1,092 in 2025
The $1,092 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,272 · 2020: $2,150 · 2021: $211 · 2022: $379 · 2023: $61.76 · 2024: $337 · 2025: $1,092.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,490.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,045.52 | 2019-2025 | Ams 800 Artificial Urinary Sphincter |
| Medtronic, INC. | $569.21 | 2022-2025 | Interstim, Altaviva |
| Coloplast Corp | $408.97 | 2019-2025 | Speedicath |
| Medtronic USA, INC. | $261.54 | 2019-2020 | |
| Innovation Technologies INC | $188.54 | 2025 | Irrisept |
| Procept Biorobotics Corporation | $169.56 | 2024-2025 | Aquabeam System |
| Sumitomo Pharma America, INC. | $147.05 | 2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $139.17 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $133.07 | 2021-2022 | |
| Edap Technomed INC | $66.55 | 2022 | |
| Cycle Pharmaceuticals INC | $60.51 | 2025 | Venxxiva, Sajazir |
| Tempus Ai, INC | $53.60 | 2024 | |
| Profound Medical Corp. | $42.30 | 2025 | Tulsa-Pro |
| Convatec INC. | $30.63 | 2025 | |
| Richard Wolf Medical Instruments Corp. | $28.94 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $28.78 | 2025 | Rivfloza |
| Axonics, INC. | $22.86 | 2022 | |
| Sagent Pharmaceuticals | $19.85 | 2021 | |
| Mimedx Group, INC. | $17.47 | 2024 | |
| Urogen Pharma, INC. | $17.22 | 2020 | |
| Ferring Pharmaceuticals INC. | $14.15 | 2019 | |
| Abc Home Medical Supply, INC. | $13.34 | 2022 | |
| Srs Medical Systems, INC. | $12.52 | 2022 | |
| Myriad Genetic Laboratories, INC. | $11.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Albo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.